Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature.

Autor:	TAKAYOSHI KIBA1,2 takkiba@hotmail.com, NAO MORII3, HIROTOSHI TAKAHASHI3, SHINJI OZAKI3, MISAO ATSUMI4, FUMI MASUMOTO4, HIROYASU YAMASHIRO3,5
Zdroj:	Oncology Letters. May2016, Vol. 11 Issue 5, p3064-3070. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu